These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9796363)

  • 1. What are we measuring with PET?
    Morgan AE; Brodie JD; Dewey SL
    Q J Nucl Med; 1998 Sep; 42(3):151-7. PubMed ID: 9796363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights.
    Laruelle M; Huang Y
    Q J Nucl Med; 2001 Jun; 45(2):124-38. PubMed ID: 11476162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of neuroreceptor imaging to psychiatry research.
    Smith GS; Koppel J; Goldberg S
    Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of neurochemical effects of cocaine and other stimulants in the human brain.
    Baxter LR; Schwartz JM; Phelps ME; Mazziotta JC; Barrio J; Rawson RA; Engel J; Guze BH; Selin C; Sumida R
    J Clin Psychiatry; 1988 Feb; 49 Suppl():23-6. PubMed ID: 3257485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-associated functional impairments of specific neurotransmitter systems: detection by pharmacological brain metabolism studies and criteria for design of human investigations.
    Soncrant TT
    Int J Clin Pharmacol Res; 1990; 10(1-2):27-47. PubMed ID: 1974889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET and drug research and development.
    Fowler JS; Volkow ND; Wang GJ; Ding YS; Dewey SL
    J Nucl Med; 1999 Jul; 40(7):1154-63. PubMed ID: 10405137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of clinical dopamine imaging.
    Lindsey KP; Gatley SJ
    Neuroimaging Clin N Am; 2006 Nov; 16(4):553-73, vii-viii. PubMed ID: 17148019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography for quantitative in vivo studies of neurotransmitter kinetics: a critical evaluation.
    Greitz T
    Adv Biochem Psychopharmacol; 1984; 39():69-78. PubMed ID: 6147069
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of positron emission tomography to study cocaine in the human brain.
    Volkow ND; Fowler JS; Wolf AP
    NIDA Res Monogr; 1991; 112():168-79. PubMed ID: 1753998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in neural science: clinical implications.
    Murphree HB
    Clin Ther; 1985; 7(2):132-42. PubMed ID: 2859115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Processes in the living brain can now be measured].
    Roland PE
    Lakartidningen; 1990 Dec; 87(49):4205-8. PubMed ID: 2175822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurotransmission in human brains measured by positron emission tomography (PET)].
    Yanai K
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):259-70. PubMed ID: 9253773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropharmacology and receptor studies in the elderly.
    Meltzer CC
    J Geriatr Psychiatry Neurol; 1999; 12(3):137-49. PubMed ID: 10593702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug development for neurodegenerative diseases: role of PET.
    Rinne JO
    Ann Med; 1999 Dec; 31(6):444-9. PubMed ID: 10680860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The study of neurotransmitter interactions using positron emission tomography and functional coupling.
    Schloesser R; Simkowitz P; Bartlett EJ; Wolkin A; Smith GS; Dewey SL; Brodie JD
    Clin Neuropharmacol; 1996 Oct; 19(5):371-89. PubMed ID: 8889281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can we measure substrate, metabolite and neurotransmitter concentrations in the human brain?
    Hutchinson PJ; O'Connell MT; Kirkpatrick PJ; Pickard JD
    Physiol Meas; 2002 May; 23(2):R75-109. PubMed ID: 12051319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.